Metabolic syndrome and liver cancer: Is excess iron the link?

Hepatology

Volumn 54, Issue 4, 2011, Pages 1487-1487

  Mascitelli, Luca ^a   Goldstein, Mark R ^b  

^a Medical Service   (Italy)

^b Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

CANCER RISK; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; HYPERFERRITINEMIA; INSULIN RESISTANCE; IRON BLOOD LEVEL; IRON DEPLETION; IRON RESTRICTION; IRON STORAGE; LETTER; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER NECROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PHLEBOTOMY; PRIORITY JOURNAL; RISK FACTOR; STELLATE CELL;

COMORBIDITY; FEMALE; HUMANS; INCIDENCE; IRON OVERLOAD; LIVER NEOPLASMS; MALE; METABOLIC SYNDROME X; PROGNOSIS; RISK ASSESSMENT;

EID: 80053337278     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24437     Document Type: Letter

References (7)

1. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: A population-based case-control study. HEPATOLOGY 2011;52. doi:10.1002/hep.24397.
2. Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005; 28: 2061-2063.
3. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol 2007; 46: 700-707.
4. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318.
5. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 2007; 102: 1251-1258.
6. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loréal O, Campion JP, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. HEPATOLOGY 1995; 22: 446-450.
7. Kato J, Miyanishi K, Kobune M, Nakamura T, Takada K, Takimoto R, et al. Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol 2007; 42: 830-836.